ConductScience.org, home

Paper20177667

Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.

Faouzi M and 3 others. J Membr Biol, 2010. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells. Papers, record 20177667. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20177667

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
PubMed
Journal
J Membr Biol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2022-02-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Faouzi MMalika
2Chopin VValérie
3Ahidouch AAhmed
4Ouadid-Ahidouch HHalima

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Intermediate-Conductance Calcium-Activated Potassium ChannelsMajor topic
Janus Kinase 2Major topic
Receptors, ProlactinMajor topic
Breast Neoplasms
Calcium
Cell Line, Tumor
Cell Proliferation
Clotrimazole
Female
Humans
Prolactin
Pyrazoles
Tyrphostins

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116489055Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.Cancer Res2006https://conductscience.org/library/papers/16489055PubMed
211572805Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.J Endocrinol2001https://conductscience.org/library/papers/11572805PubMed
311923474PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.Mol Endocrinol2002https://conductscience.org/library/papers/11923474PubMed
414586031Effects of prolactin on ionic membrane conductances in the human malignant astrocytoma cell line U87-MG.J Neurophysiol2004https://conductscience.org/library/papers/14586031PubMed
58663214Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay.J Biol Chem1996https://conductscience.org/library/papers/8663214PubMed
611032019Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.Oncogene2000https://conductscience.org/library/papers/11032019PubMed
79723866Prolactin induces an inward current through voltage-independent Ca2+ channels in Chinese hamster ovary cells stably expressing prolactin receptor.J Mol Endocrinol1998https://conductscience.org/library/papers/9723866PubMed
814985237Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression.Am J Physiol Cell Physiol2004https://conductscience.org/library/papers/14985237PubMed
912826234Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation.Eur J Pharmacol2003https://conductscience.org/library/papers/12826234PubMed
1018246319Prolactin and breast cancer etiology: an epidemiologic perspective.J Mammary Gland Biol Neoplasia2008https://conductscience.org/library/papers/18246319PubMed
1114978241Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro.Mol Pharmacol2004https://conductscience.org/library/papers/14978241PubMed
129774475Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry.J Biol Chem1998https://conductscience.org/library/papers/9774475PubMed
1312588805The role of prolactin in mammary carcinoma.Endocr Rev2003https://conductscience.org/library/papers/12588805PubMed
1412825859Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.Breast Cancer Res Treat2003https://conductscience.org/library/papers/12825859PubMed
1518060344K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis.J Membr Biol2008https://conductscience.org/library/papers/18060344PubMed
1614565846Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation.Biochem J2004https://conductscience.org/library/papers/14565846PubMed
1711968058Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells.Glia2002https://conductscience.org/library/papers/11968058PubMed
1819153125Re-evaluation of the prolactin receptor expression in human breast cancer.J Endocrinol2009https://conductscience.org/library/papers/19153125PubMed
191718958A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor.J Biol Chem1991https://conductscience.org/library/papers/1718958PubMed
207534043Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.Am J Pathol1995https://conductscience.org/library/papers/7534043PubMed

See all 42 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
33521321Targeting the JAK/STAT pathway in solid tumors.J Cancer Metastasis Treat2020https://conductscience.org/library/papers/33521321PubMed
28557306SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer.Mol Oncol2017https://conductscience.org/library/papers/28557306PubMed
28530221MICU1 drives glycolysis and chemoresistance in ovarian cancer.Nat Commun2017https://conductscience.org/library/papers/28530221PubMed
28280257Intermediate-Conductance-Ca2-Activated K Channel IKCa1 Is Upregulated and Promotes Cell Proliferation in Cervical CancerMed Sci Monit Basic Res2017https://conductscience.org/library/papers/28280257PubMed
27814637Zinc transporters and dysregulated channels in cancers.Front Biosci (Landmark Ed)2017https://conductscience.org/library/papers/27814637PubMed
27531900miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.Oncotarget2016https://conductscience.org/library/papers/27531900PubMed
27183905Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis.Oncotarget2016https://conductscience.org/library/papers/27183905PubMed
27069638Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.Pharmacol Res Perspect2016https://conductscience.org/library/papers/27069638PubMed
26350345X-ray irradiation activates K+ channels via H2O2 signaling.Sci Rep2015https://conductscience.org/library/papers/26350345PubMed
24336491The roles of K(+) channels in cancer.Nat Rev Cancer2014https://conductscience.org/library/papers/24336491PubMed
24116006Altered expression of two-pore domain potassium (K2P) channels in cancer.PLoS One2013https://conductscience.org/library/papers/24116006PubMed
23970866K(+) channels and cell cycle progression in tumor cells.Front Physiol2013https://conductscience.org/library/papers/23970866PubMed
21851427Prolactin induces a hyperpolarising current in rat paraventricular oxytocinergic neurones.J Neuroendocrinol2011https://conductscience.org/library/papers/21851427PubMed
21123738Calcium-activated K+ channels increase cell proliferation independent of K+ conductance.Am J Physiol Cell Physiol2011https://conductscience.org/library/papers/21123738PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
KCNN43783PubTator's text mininghttps://conductscience.org/library/genes/3783NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene
PRLR5618PubTator's text mininghttps://conductscience.org/library/genes/5618NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20177667

GET https://conductscience.org/api/papers/v1/20177667/references?page=2